Russia's HSCI planning IPO

Human Stem Cells Institute (Moscow, Russia) plans to sell 15 million shares at RUB9-RUB11 in an IPO underwritten by CJSC Alor Invest. A RUB10 price would raise RUB150 million ($5 million). HSCI expects to have a post-IPO market capitalization of RUB675-RUB825 million ($22.7-$27.7 million). ...